Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Dikang Pharmaceutical Co., Ltd. is a specialized pharmaceutical and medical device manufacturer based in Chongqing, China, and a key subsidiary of Haisco Pharmaceutical Group. The company is recognized for its leadership in the development of bio-absorbable materials, notably its polylactic acid-based medical films used to prevent post-operative adhesions. In addition to its medical device portfolio, Chongqing Dikang produces a range of chemical drugs, including the widely used Loxoprofen Sodium gel patch for pain and inflammation. The company's operations are integrated into Haisco's broader strategy to dominate the surgical and analgesic markets in China. Its manufacturing facilities are GMP-certified, ensuring high-quality production of both small molecule therapeutics and specialized surgical aids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Dikang.